£176.82

Springer Recombinant Protein Production with Prokaryotic and Eukaryotic Cells. A Comparative View on Host Physiology: Selected articles from the Meeting of the ... Semmering, Austria, 5th–8th October 2000

Price data last checked 23 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£177 today · previous high £177 · all-time low £175

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 68 days • 68 data points (No recent data available)

Historical
Generating forecast...
£176.82 £174.74 £175.19 £175.65 £176.10 £176.56 £177.01 06 April 2026 22 April 2026 09 May 2026 26 May 2026 12 June 2026

Price Distribution

Price distribution over 68 days • 2 price levels

Days at Price
Current Price
41 days 27 days · current 0 10 21 31 41 £175 £177 Days at Price

Price Analysis

Most common price: £175 (41 days, 60.3%)

Price range: £175 - £177

Price levels: 2 different prices over 68 days

Description

More then 20 years have passed now since the first recombinant protein producing microorganisms have been developed. In the meanwhile, numerous proteins have been produced in bacteria, yeasts and filamentous fungi, as weIl as higher eukaryotic cells, and even entire plants and animals. Many recombinant proteins are on the market today, and some of them reached substantial market volumes. On the first sight one would expect the technology - including the physiology of the host strains - to be optimised in detail after a 20 year's period of development. However, several constraints have limited the incentive for optimisation, especially in the pharmaceutical industry like the urge to proceed quickly or the requirement to define the production parameters for registration early in the development phase. The additional expenses for registration of a new production strain often prohibits a change to an optimised strain. A continuous optimisation of the entire production process is not feasible for the same reasons.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
30 November 2001
Listed Since
27 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Commercial Plant-Produced Recombinant Protein Products: Case Studies: 68 (Biotechnology in Agriculture and Forestry, 68)
79% match

Commercial Plant-Produced Recombinant Protein Products: Case Studies: 68 (Biotechnology in Agriculture and Forestry, 68)

Springer

£75.25 05 Jun 2026
Reprogramming Microbial Metabolic Pathways: 64 (Subcellular Biochemistry, 64)
78% match

Reprogramming Microbial Metabolic Pathways: 64 (Subcellular Biochemistry, 64)

Springer

£107.98 24 May 2026
Protein Engineering: 22 (Nucleic Acids and Molecular Biology, 22)
78% match

Protein Engineering: 22 (Nucleic Acids and Molecular Biology, 22)

Springer

£143.02 31 May 2026
Animal Cell Technology: Products from Cells, Cells as Products: Proceedings of the 16th ESACT Meeting April 25–29, 1999, Lugano, Switzerland
77% match

Animal Cell Technology: Products from Cells, Cells as Products: Proceedings of the 16th ESACT Meeting April 25–29, 1999, Lugano, Switzerland

Springer

£175.98 01 Jun 2026
Recombinant Protein Production in Yeast: Methods and Protocols: 866 (Methods in Molecular Biology, 866)
77% match

Recombinant Protein Production in Yeast: Methods and Protocols: 866 (Methods in Molecular Biology, 866)

Humana

£80.64 06 Jun 2026
Life Sciences Industry: From Laboratories to Commercialization of Research: 2 (New Paradigms of Living Systems, 2)
77% match

Life Sciences Industry: From Laboratories to Commercialization of Research: 2 (New Paradigms of Living Systems, 2)

Springer

£91.52 11 Jun 2026
Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)
77% match

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

Springer

£237.20 13 Jun 2026
Biotechnology of Antibiotics and Other Bioactive Microbial Metabolites
77% match

Biotechnology of Antibiotics and Other Bioactive Microbial Metabolites

Springer

£107.86 31 May 2026
Biotechnology of Yeasts and Filamentous Fungi
77% match

Biotechnology of Yeasts and Filamentous Fungi

Springer

£108.92 18 May 2026
Novel Frontiers in the Production of Compounds for Biomedical Use: 1 (Focus on Biotechnology, 1)
76% match

Novel Frontiers in the Production of Compounds for Biomedical Use: 1 (Focus on Biotechnology, 1)

Springer

£113.76 29 Jun 2026
Physical Methods to Characterize Pharmaceutical Proteins: 7 (Pharmaceutical Biotechnology, 7)
76% match

Physical Methods to Characterize Pharmaceutical Proteins: 7 (Pharmaceutical Biotechnology, 7)

Springer

£108.75 18 May 2026
Protein Therapeutics: 21 (Topics in Medicinal Chemistry, 21)
76% match

Protein Therapeutics: 21 (Topics in Medicinal Chemistry, 21)

Springer

£162.87 01 Jun 2026
Cell Free Synthesis of Biologics: A Comprehensive Guide
76% match

Cell Free Synthesis of Biologics: A Comprehensive Guide

Academic Press

£157.99 26 May 2026
Recent Advances in Biotechnology: Proceedings of the NATO Advanced Study Institute on Recent Advances in Industrial Applications of Biotechnology, ... (NATO Science Series: E: Applied Sciences)
76% match

Recent Advances in Biotechnology: Proceedings of the NATO Advanced Study Institute on Recent Advances in Industrial Applications of Biotechnology, ... (NATO Science Series: E: Applied Sciences)

Springer

£77.64 21 May 2026
Applied Microbiology: 2 (Focus on Biotechnology, 2)
76% match

Applied Microbiology: 2 (Focus on Biotechnology, 2)

Springer

£74.72 13 Jun 2026
Recombinant Protein Drugs (Milestones in Drug Therapy)
76% match

Recombinant Protein Drugs (Milestones in Drug Therapy)

Birkhauser

£113.76 30 May 2026
From Clone to Clinic: 1 (Developments in Biotherapy, 1)
76% match

From Clone to Clinic: 1 (Developments in Biotherapy, 1)

Springer

£75.60 18 May 2026
Metabolic Engineering for Bioprocess Commercialization
76% match

Metabolic Engineering for Bioprocess Commercialization

Springer

£73.01 31 May 2026
Microbial Engineering for Therapeutics
76% match

Microbial Engineering for Therapeutics

Springer

£149.86 13 Jun 2026
Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts (Wiley Series in Biotechnology and Bioengineering)
76% match

Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts (Wiley Series in Biotechnology and Bioengineering)

Wiley

£97.00 28 May 2026
Technological and Medical Implications of Metabolic Control Analysis: 74 (NATO Science Partnership Subseries: 3, 74)
75% match

Technological and Medical Implications of Metabolic Control Analysis: 74 (NATO Science Partnership Subseries: 3, 74)

Springer

£34.49 15 Jun 2026
Biochemical Engineering for 2001: Proceedings of Asia-Pacific Biochemical Engineering Conference 1992
75% match

Biochemical Engineering for 2001: Proceedings of Asia-Pacific Biochemical Engineering Conference 1992

Springer

£78.84 11 Jun 2026
Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)
75% match

Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)

Springer

£107.78 03 Jun 2026
Recombinant Gene Expression: Reviews and Protocols: 267 (Methods in Molecular Biology, 267)
75% match

Recombinant Gene Expression: Reviews and Protocols: 267 (Methods in Molecular Biology, 267)

Humana

£108.92 04 Jun 2026